Cooley Simultaneously Handles Billion Dollar Deals
Cooley's M&A team, led by San Diego-based partners Barbara Borden and Rama Padmanabhan, represented companies in two separate pharma deals that signed on March 30.
"Cooley Advises on Twin Pharma Deals Worth $4.6 Billion ," The Recorder
"Cooley Advises on Pair of Pharma Deals Worth $4.6B," Daily Journal
|
In the first deal, Cooley advised La Jolla, California-based Auspex in its $3.5 billion sale to Jerusalem-based Teva Pharmaceuticals Industries Ltd. "Teva to Buy Auspex for $3.5 Billion to Boost Neurology Arm ," Bloomberg "Auspex Pharmaceuticals Acquired By Teva For $3.2 Billion ," SoCal Tech |
|
In the second deal, Cooley represented Horizon Pharma PLC, based in Ireland, in its purchase of Hyperion Therapeutics Inc. for $1.1 billion. "Horizon to Buy Hyperion for $1.1 Billion, Gain Orphan Drugs ," Bloomberg "Horizon Pharma To Buy Hyperion Therapeutics For $1.1B ," Law360 "Ireland's Horizon to Buy U.S. Drugmaker Hyperion for $1.1 Billion ," Reuters "Dublin-Based Horizon Pharma Set to Buy Hyperion for $1.1BN ," RTE News "Horizon Pharma (HZNP) to Acquire Hyperion Therapeutics (HPTX) in $1.1B Deal," Street Insider |
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.